$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Total Artificial Heart - Medical Devices Pipeline Assessment, 2016
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 01 Jun 2016 | 26555 | In Stock
Related Topics: Medical , Medical Devices

Introduction

Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Total Artificial Heart - Medical Devices Pipeline Assessment, 2016" provides an overview of Total Artificial Heart currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Total Artificial Heart pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type

Scope

- Extensive coverage of the Total Artificial Heart under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Total Artificial Heart under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
for Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

  • 1 Table of Contents

    1 Table of Contents 2

    1.1 List of Tables 4

    1.2 List of Figures 5

    2 Introduction 6

    2.1 Total Artificial Heart Overview 6

    3 Products under Development 7

    3.1 Total Artificial Heart - Pipeline Products by Stage of Development 7

    3.2 Total Artificial Heart - Pipeline Products by Territory 8

    3.3 Total Artificial Heart - Pipeline Products by Regulatory Path 9

    3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date 10

    3.5 Total Artificial Heart - Ongoing Clinical Trials 11

    4 Total Artificial Heart - Pipeline Products under Development by Companies 12

    4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development 12

    4.2 Total Artificial Heart - Pipeline Products by Stage of Development 13

    5 Total Artificial Heart Companies and Product Overview 14

    5.1 Abiomed, Inc. Company Overview 14

    5.1.1 Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

    5.2 BiVacor Pty Ltd Company Overview 16

    5.2.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

    5.3 Carmat SAS Company Overview 17

    5.3.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 17

    5.4 Cleveland Heart, Inc. Company Overview 21

    5.4.1 Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

    5.5 Foster-Miller, Inc. (Inactive) Company Overview 23

    5.5.1 Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23

    5.6 MicroMed Cardiovascular, Inc. Company Overview 24

    5.6.1 MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24

    5.7 SynCardia Systems, Inc. Company Overview 25

    5.7.1 SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25

    5.8 The University of Tokyo Company Overview 34

    5.8.1 The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 34

    6 Total Artificial Heart- Recent Developments 35

    6.1 Apr 13, 2016: World’s Leading Artificial Heart Center, La Pitié Hospital, Paris, Celebrates 30 Years and 249 Implants of the SynCardia Total Artificial Heart 35

    6.2 Feb 29, 2016: Early Findings of the 50cc SynCardia Heart Indicate That It Fits Underserved Patients - Women & Adolescents 36

    6.3 Feb 26, 2016: Carmat Raises USD55 Million in Private Placement of Shares 37

    6.4 Jan 26, 2016: Altaris Capital Partners Acquires Minority Interest in Minnetronix for USD20 Million 37

    6.5 Jan 21, 2016: Information regarding the Feasibility study of the CARMAT bioprosthetic artificial heart 37

    6.6 Nov 12, 2015: Arrhythmia Research Technology Reports 2015 Third Quarter Results 38

    6.7 Sep 16, 2015: SynCardia Systems Withdraws IPO for up to USD30 Million 39

    6.8 Aug 31, 2015: Interim Results of the Feasibility Study Presented at the ESC Congress in London 40

    6.9 Aug 18, 2015: The Start of SynCardia Total Artificial Heart Destination Clinical Study Wins Edison Awards’ Top Honor 40

    6.10 Jun 15, 2015: SynCardia Systems - TAH-t Companion 2 Driver System - Letter to Health Care Providers 41

    6.11 Jun 03, 2015: Carmat To Implant Artificial Heart In Fourth Patient In Next Three Months 42

    7 Appendix 43

    7.1 Methodology 43

    7.2 About GlobalData 45

    7.3 Contact Us 46

    7.4 Disclaimer 46

List Of Tables
in Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

1.1 List of Tables

Table 1: Total Artificial Heart - Pipeline Products by Stage of Development 7

Table 2: Total Artificial Heart - Pipeline Products by Territory 8

Table 3: Total Artificial Heart - Pipeline Products by Regulatory Path 9

Table 4: Total Artificial Heart - Pipeline Products by Estimated Approval Date 10

Table 5: Total Artificial Heart - Ongoing Clinical Trials 11

Table 6: Total Artificial Heart Companies - Pipeline Products by Stage of Development 12

Table 7: Total Artificial Heart - Pipeline Products by Stage of Development 13

Table 8: Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: AbioCor II - Product Status 15

Table 10: AbioCor II - Product Description 15

Table 11: BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: BiVACOR Device - Product Status 16

Table 13: BiVACOR Device - Product Description 16

Table 14: Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 17

Table 15: Artificial Heart - Product Status 18

Table 16: Artificial Heart - Product Description 18

Table 17: Carmat SAS - Ongoing Clinical Trials Overview 19

Table 18: Artificial Heart - First-in-man CARMAT’s Bioprosthetic Heart Trial For End-stage Heart Failure 20

Table 19: Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 20: SmartHeart TAH - Product Status 22

Table 21: SmartHeart TAH - Product Description 22

Table 22: Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23

Table 23: MagScrew Total Artificial Heart - Product Status 23

Table 24: MagScrew Total Artificial Heart - Product Description 23

Table 25: MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24

Table 26: Pulse Less Total Artificial Heart - Product Status 24

Table 27: Pulse Less Total Artificial Heart - Product Description 24

Table 28: SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25

Table 29: 50cc Total Artificial Heart - Adults Bridge To Transplant - Product Status 26

Table 30: 50cc Total Artificial Heart - Adults Bridge To Transplant - Product Description 26

Table 31: 50cc Total Artificial Heart - Destination Therapy - Product Status 27

Table 32: 50cc Total Artificial Heart - Destination Therapy - Product Description 27

Table 33: 50cc Total Artificial Heart - Pediatric Bridge To Transplant - Product Status 28

Table 34: 50cc Total Artificial Heart - Pediatric Bridge To Transplant - Product Description 28

Table 35: SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy - Product Status 29

Table 36: SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy - Product Description 29

Table 37: SynCardia Systems, Inc. - Ongoing Clinical Trials Overview 30

Table 38: SynCardia Temporary 70cc Total Artificial Heart - Destination Therapy - SynCardia 70cc Temporary Total Artificial Heart (TAH-t) for Destination Therapy (DT) 31

Table 39: 50cc Total Artificial Heart - Pediatric Bridge To Transplant - SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant 32

Table 40: 50cc Total Artificial Heart - Adults Bridge To Transplant - SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant 33

Table 41: The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 34

Table 42: Total Artificial Heart - Product Status 34

Table 43: Total Artificial Heart - Product Description 34

Table 44: Glossary 44

List Of Figures, Charts and Diagrams
in Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

1.2 List of Figures

Figure 1: Total Artificial Heart - Pipeline Products by Stage of Development 7

Figure 2: Total Artificial Heart - Pipeline Products by Territory 8

Figure 3: Total Artificial Heart - Pipeline Products by Regulatory Path 9

Figure 4: Total Artificial Heart - Pipeline Products by Estimated Approval Date 10

Figure 5: Total Artificial Heart - Ongoing Clinical Trials 11

Additional Details

Publisher

Global Data

Publisher Information

Reference

26555 | GDME0188EPD

Number of Pages

46

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Venipuncture Procedure Analysis By Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) - Global Forecast to 2021
Venipuncture is the procedure of collecting blood from veins for diagnostic purposes. Procedures con...
15 Mar 2017 by MarketsandMarkets USD $7,150 More Info
2017 Total Protein Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
This new report from VPGMarketResearch provides analysis of Total Protein testing, including clinica...
07 Mar 2017 by Venture Planning Group (VPG) USD $1,650 More Info
2017 IgE Total Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
This new report from VPGMarketResearch.com provides analysis of IgE Total testing, including clinica...
07 Mar 2017 by Venture Planning Group (VPG) USD $1,650 More Info
Extremity Reconstruction Market By Type (Upper Extremity, Lower Extremity, Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow, Hand and Wrist, Hind foot Fusion, Ankle Fusion, Ankle Replacement), Biomaterials (Metallic, Polymeric, Ceramic and Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Extremities are external articulated organs, which execute various locomotive functions. The human b...
01 Sep 2016 by Allied Market Research USD $5,370 More Info
Total Protein Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
This new report from VPGMarketResearch provides analysis of Total Protein testing, including clinica...
29 Jul 2016 by Venture Planning Group (VPG) USD $750 More Info
IgE Total Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
This new report from VPG Market Research provides analysis of IgE Total testing, including clinical ...
29 Jul 2016 by Venture Planning Group (VPG) USD $750 More Info
Total Artificial Heart - Medical Devices Pipeline Assessment, 2016
Total Artificial Heart - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Device...
01 Jun 2016 by Global Data USD $2,500 More Info
Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), Technology (Column-, Reagent-, Magnetic Bead-based), Application (Plasmid, Genomic DNA, miRNA, Total RNA, PCR Clean-up), & End Users - Global Forecast to 2020
The global nucleic acid isolation and purification market is expected to reach USD 3,837.42 million ...
04 Nov 2015 by MarketsandMarkets USD $5,650 More Info
Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019
The interventional cardiology and peripheral vascular devices market is expected to reach .72 bil...
03 Jun 2015 by MarketsandMarkets USD $5,650 More Info
Lab Automation Market by Equipment & Software (Robotic Arm, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics), Type of Automation (Modular, Total Lab), & End Users (Biotechnology & Pharmaceuticals) - Global Forecasts to 2020
The report segments the lab automation market on the basis of equipment and software, application, t...
30 Apr 2015 by MarketsandMarkets USD $5,650 More Info

This report is published by Global Data

Download Free Report Summary PDF

Total Artificial Heart - Medical Devices Pipeline Assessment, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...